• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Primary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Primary alcohols

Comprehensive Analysis of 2-BUTYNE-1,4-DIOL-(1,1,4,4)-D4 (CAS No. 688790-78-5): Properties, Applications, and Industry Trends

In the realm of isotopic labeling and specialty chemicals, 2-BUTYNE-1,4-DIOL-(1,1,4,4)-D4 (CAS No. 688790-78-5) stands out as a deuterated derivative of 2-butyne-1,4-diol. This compound has garnered significant attention due to its unique molecular structure, where four hydrogen atoms are replaced with deuterium (D4 labeling), enhancing its utility in NMR spectroscopy, metabolic studies, and pharmaceutical research. The growing demand for isotopically labeled compounds in drug discovery and life sciences underscores the relevance of this chemical.

The deuterium-enriched nature of 2-BUTYNE-1,4-DIOL-D4 offers distinct advantages in kinetic isotope effect (KIE) studies, enabling researchers to investigate reaction mechanisms with higher precision. Recent advancements in proteomics and biomarker discovery have further propelled its adoption, as it aids in reducing signal overlap in complex biological matrices. Industry reports highlight a surge in queries related to "deuterated solvents" and "stable isotope applications," reflecting broader trends in precision medicine and diagnostic imaging.

From a synthetic perspective, CAS 688790-78-5 is synthesized through catalytic deuteration of its protonated counterpart, ensuring high isotopic purity (>98%). Its molecular stability and compatibility with organic reaction conditions make it a preferred choice for cross-coupling reactions and polymer chemistry. Notably, its role in click chemistry applications has been explored in peer-reviewed journals, aligning with the rising interest in "bioorthogonal chemistry" and "material science innovations."

Environmental and regulatory considerations are also pivotal. Unlike non-deuterated analogs, 2-BUTYNE-1,4-DIOL-(1,1,4,4)-D4 exhibits altered physicochemical properties, influencing its biodegradation profile. This aspect resonates with the "green chemistry" movement, where researchers prioritize sustainable synthesis and eco-friendly solvents. Analytical techniques such as LC-MS and GC-IRMS are routinely employed to validate its purity, addressing the demand for "high-purity standards" in quality control laboratories.

Market dynamics reveal that 688790-78-5 is predominantly supplied by specialty chemical manufacturers catering to academic institutions and pharmaceutical giants. The compound's pricing reflects the complexities of deuterium incorporation and scale-up challenges, topics frequently searched in chemical procurement forums. Additionally, its integration into PET tracer development and drug metabolite identification has been documented in recent patents, signaling its expanding role in translational research.

Future prospects for 2-BUTYNE-1,4-DIOL-D4 are intertwined with advancements in isotope-enriched therapeutics and catalysis. As industries pivot toward personalized medicine, the need for deuterium-labeled APIs (active pharmaceutical ingredients) is anticipated to rise. Concurrently, innovations in flow chemistry and continuous manufacturing could streamline its production, addressing scalability concerns—a recurring theme in process chemistry discussions.

In summary, 2-BUTYNE-1,4-DIOL-(1,1,4,4)-D4 (CAS No. 688790-78-5) exemplifies the intersection of isotopic labeling and cutting-edge research. Its multifaceted applications, from mechanistic studies to industrial catalysis, position it as a critical tool in modern chemistry. For researchers navigating the "deuterated compounds market" or seeking "NMR shift references," this compound offers both versatility and scientific rigor.

• 764-01-2(2-Butyn-1-ol)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)